MIOSIS DURING L-DOPA THERAPY

被引：14

作者：

SPIERS, ASD

CALNE, DB

FAYERS, PM

机构：

来源：

BRITISH MEDICAL JOURNAL | 1970年 / 2卷 / 5710期

关键词：

D O I：

10.1136/bmj.2.5710.639

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：639 / &

共 50 条

[21] METHYLDOPAHYDRAZINE AS AN ADJUNCT TO L-DOPA THERAPY IN PARKINSONISM
CHASE, TN
WATANABE, AM
NEUROLOGY, 1972, 22 (04) : 384 - &
[22] PAROSMIA AND ANOSMIA UNDER L-DOPA THERAPY
NEUNDORFER, B
VALDIVIESO, T
NERVENARZT, 1977, 48 (05): : 283 - 284
[23] EVALUATION OF L-DOPA THERAPY IN PARKINSONS DISEASE
MONES, RJ
ELIZAN, TS
SIEGEL, GJ
NEW YORK STATE JOURNAL OF MEDICINE, 1970, 70 (18) : 2309 - &
[24] EEG EFFECTS OF L-DOPA THERAPY IN PARKINSONISM
MARJERRISON, G
BOULTON, AA
RAJPUT, AH
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1971, 31 (06): : 635 - +
[25] L-Dopa Therapy in Angelman Syndrome of Childhood
Lavenstein, Bennett
Gropman, Andrea
NEUROLOGY, 2010, 74 (09) : A273 - A273
[26] L-DOPA THERAPY IN PARKINSONISM - MECHANISM OF ACTION
SANDLER, M
PSYCHIATRIA NEUROLOGIA NEUROCHIRURGIA, 1971, 74 (04): : 331 - &
[27] CHANGES IN TASTE UNDER L-DOPA THERAPY
SIEGFRIED, J
ZEITSCHRIFT FUR NEUROLOGIE, 1971, 200 (04): : 345 - +
[28] SEROLOGIC ABNORMALITIES ASSOCIATED WITH L-DOPA THERAPY
HENRY, RE
GOLDBERG, LS
STURGEON, P
ANSEL, RD
VOX SANGUINIS, 1971, 20 (04) : 306 - &
[29] URINARY METABOLITES OF L-DOPA DURING LONG-TERM TREATMENT OF PARKINSONIAN PATIENTS WITH L-DOPA
SIIRTOLA, T
SONNINEN, V
RINNE, UK
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1972, 31 : 66 - &
[30] CURRENT TRENDS IN L-DOPA THERAPY OF PARKINSONISM
PETERSON, DI
HUNT, GM
CALIFORNIA MEDICINE, 1972, 117 (05): : 58 - 59